A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...
MedPage Today on MSN
Novel ICD lead for conduction system pacing enters the arena
First-in-human report for UltiSynq CSP ICD lead ...
The two regional studies utilized a lumenless, bipolar, permanent pacing lead (SelectSecure™ lead model 3830, Medtronic, Inc.) (Fig. 1). This 4.1-Fr-diameter, active fixation, steroid-eluting lead is ...
GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded ...
Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...
A first-in-human multicenter trial found the UltiSynq CSP ICD lead, designed for left bundle branch area pacing, met and exceeded safety and effectiveness goals in over 200 patients needing ICD or CRT ...
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results